Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Ohio
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Ohio
7 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Ohio.
Cities in Ohio
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Cleveland Clinic Main Campus, Cleveland
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05327114A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- University of Cincinnati Health, Cincinnati
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06920004A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- University of Cincinnati Medical Center- Site Number : 8400020, Cincinnati
- University Hospitals Cleveland Medical Center- Site Number : 8400033, Cleveland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06290141Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1624, Canton
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07032662A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Cleveland
- TG Therapeutics Investigational Trial Site, Columbus
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06680037A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Clinical Study Site, Cincinnati
- Clinical Study Site, Columbus
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT06858579A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Cleveland Clinic, Cleveland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 20, 2026 · NCT06747351From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.